VivoSim Labs (VIVS) Other Non-Current Liabilities (2011 - 2014)
VivoSim Labs (VIVS) posted quarterly Other Non-Current Liabilities of $377000.0 for Q1 2014, down 94.53% year-over-year from $6.9 million in Q1 2013, and down 62.52% quarter-over-quarter from $1.0 million in Q4 2013.
VivoSim Labs (VIVS) Other Non-Current Liabilities (2011 - 2014) Analysis & Trends
VivoSim Labs' Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $377000.0 for Q1 2014.
- In Q1 2014, Other Non-Current Liabilities fell 94.53% year-over-year to $377000.0; the TTM figure through Mar 2014 stood at $377000.0 (down 94.53% YoY), while the FY2014 annual figure was $377000.0, down 94.53% from the prior year.
- Other Non-Current Liabilities for Q1 2014 stood at $377000.0, down from $1.0 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $80.6 million in Q2 2012, with the low at $377000.0 in Q1 2014.
- The 4-year median for Other Non-Current Liabilities is $6.9 million (2013), against an average of $21.6 million.
- The sharpest annual moves came in 2012 and 2013: Other Non-Current Liabilities jumped 1527.39% in 2012, then tumbled 97.76% in 2013.
- VivoSim Labs' Other Non-Current Liabilities stood at $1.3 million in 2011, then surged by 1527.39% to $20.6 million in 2012, then sank by 95.12% to $1.0 million in 2013, then slumped by 62.52% to $377000.0 in 2014.
- Business Quant data shows VIVS's Other Non-Current Liabilities at $377000.0 in Q1 2014, $1.0 million in Q4 2013, and $795000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 377,000.00 |
| Dec 31, 2013 | 1.01 Mn |
| Sep 30, 2013 | 795,000.00 |
| Mar 31, 2013 | 6.90 Mn |
| Dec 31, 2012 | 20.62 Mn |
| Sep 30, 2012 | 35.47 Mn |
| Jun 30, 2012 | 80.58 Mn |
| Mar 31, 2012 | 47.51 Mn |
| Dec 31, 2011 | 1.27 Mn |